Search Result "VEGF-A/B"
Changes in the Expression Profile of VEGF-A, VEGF-B, VEGFR-1, VEGFR-2 in Different Grades of Endometrial Cancer
Journal: Current Pharmaceutical Biotechnology
Volume: 20 Issue: 1 Year: 2019 Page: 955-963
Author(s): Konrad Dziobek,Marcin Opławski,Beniamin Oskar Grabarek,Nikola Zmarzły,Barbara Tomala,Tomasz Halski,Ewa Leśniak,Krzysztof Januszyk,Ryszard Brus,Robert Kiełbasiński,Dariusz Boroń
Multiple VEGF Family Members are Simultaneously Expressed in Ovarian Cancer: a Proposed Model for Bevacizumab Resistance
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 25 Year: 2012 Page: 3784-3792
Author(s): Arne R.M. van der Bilt,Ate G.J. van der Zee,Elisabeth G.E. de Vries,Steven de Jong,Hetty Timmer- Bosscha,Klaske A. ten Hoor,Wilfred F.A. den Dunnen,Harry Hollema,Anna K.L. Reyners
Combining Bevacizumab with Knocked-Down β-Catenin ReducesVEGF-A and Slug mRNA in HepG2 but not in Caco-2 Cell Lines
Journal: Current Molecular Medicine
Volume: 22 Issue: 4 Year: 2022 Page: 374-383
Author(s): Reem Mebed,Yasser BM Ali,Nahla Shehata,Abdel-Rahman Zekri,Salwa Sabet
A Pilot Study Evaluating Combinatorial and Simultaneous Delivery of Polyethylenimine-Plasmid DNA Complexes Encoding for VEGF and PDGF for Bone Regeneration in Calvarial Bone Defects
Journal: Current Pharmaceutical Biotechnology
Volume: 16 Issue: 7 Year: 2015 Page: 655-660
Author(s): Sheetal R. D'Mello,Satheesh Elangovan,Liu Hong,Ryan D. Ross,D. Rick Sumner,Aliasger K. Salem
Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect
Journal: Current Pharmaceutical Biotechnology
Volume: 22 Issue: 5 Year: 2021 Page: 697-705
Author(s): Piotr Kras,Karol Talkowski,Beniamin O. Grabarek,Nina Skalska-Dziobek,Dariusz BoroÅ,Marcin Oplawski
Aflibercept (VEGF-Trap) in High-Grade Gliomas
Ebook: Controversies in Neuro-Oncology
Volume: 1 Year: 2010
Author(s): Jan Drappatz,Andrew D. Norden,Patrick Y. Wen
Doi: 10.2174/978160805132811001010171
Vascular Endothelial Growth Factor: A New Paradigm for Targeting Various Diseases
Journal: Current Angiogenesis (Discontinued)
Volume: 4 Issue: 1 Year: 2015 Page: 24-36
Author(s): Snehal S. Patel,Niti Rajshree,Abhinav Chavada
Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 4 Year: 2013 Page: 530-540
Author(s): Tina Sharma, Richa Dhingra, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra, T. R. Bhardwaj
The Effects of Radix Curcumae Extract on Expressions of VEGF, COX-2 and PCNA in Gastric Mucosa of Rats Fed with MNNG
Journal: Current Pharmaceutical Biotechnology
Volume: 11 Issue: 3 Year: 2010 Page: 313-317
Author(s): Bin Lu, Linfeng Yu, Lei Xu, Hanqing Chen, Lu Zhang, Yanjun Zeng
Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs
Journal: Current Drug Therapy
Volume: 7 Issue: 2 Year: 2012 Page: 80-89
Author(s): Michael W. Stewart